---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-002790"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2025-04-24T23:59:59+00:00"
generated_at: "2026-05-23T06:43:59.459685+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# PharmaCyte Biotech annual meeting elects directors, ratifies auditor, approves exec compensation

## Summary
- Annual meeting held Apr 24, 2025; quorum of 3,222,988 shares (~46.92%) present.
- All five director nominees elected: Silverman, Schechter, Abecassis, Weinstein, Walker.
- CBIZ CPAs P.C. ratified as auditor for FY ending Apr 30, 2025 (for: 3,123,042; against: 72,371).
- Non-binding advisory vote approved executive compensation (for: 1,094,399; against: 113,815; abstain: 21,543).

## SEC filing metadata
- accession: 0001683168-25-002790
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2025-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316825002790/0001683168-25-002790-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316825002790/pharmacyte_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-002790
- JSON: https://secwatch.observer/filing/0001683168-25-002790.json
- Plain text: https://secwatch.observer/filing/0001683168-25-002790.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.